| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/13/2010 | CN100579978C Compounds |
| 01/13/2010 | CN100579542C Chinese medicinal herb formula for treating thrombocytopenia |
| 01/13/2010 | CN100579529C Alprostadil freeze-dried emulsion and its preparation method |
| 01/13/2010 | CN100579527C Compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes and use method thereof |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/13/2010 | CN100579517C 'Longxuejie' soft capsule and preparation method thereof |
| 01/12/2010 | US7645765 With water miscible solubilizer; phosphodiesterase inhibitors; cardiovascular disorders |
| 01/12/2010 | US7645751 Mandelic acid derivatives and their use as thrombin inhibitors |
| 01/12/2010 | US7645592 Glycoprotein VI antibodies and methods of use thereof |
| 01/12/2010 | CA2483678C 6-11 bicyclic ketolide derivatives |
| 01/12/2010 | CA2457351C Quinazolinone derivatives |
| 01/12/2010 | CA2438143C Modified proteins, designer toxins, and methods of making thereof |
| 01/07/2010 | WO2010002453A2 C-1 inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010000943A1 An intrauterine delivery system for contraception |
| 01/07/2010 | WO2009138796A3 Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents |
| 01/07/2010 | US20100004339 Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists |
| 01/07/2010 | US20100004292 Iminooxazolidine Derivatives and Their Use |
| 01/07/2010 | US20100004279 Solid medicinal preparation containing mannitol or lactose |
| 01/07/2010 | US20100004264 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/07/2010 | US20100004199 Glycine betaine and its use |
| 01/07/2010 | US20100004196 Heparan sulfate proteoglycan composition and use thereof |
| 01/07/2010 | US20100004160 Substituted fused heterocyclic c-glycosides |
| 01/07/2010 | US20100003672 Cdna for human methylenetetrahydrofolate reductase and uses thereof |
| 01/07/2010 | US20100003323 Hydrophilic matrix containing poorly water-soluble compound and method for producing the same |
| 01/07/2010 | US20100003320 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 01/07/2010 | US20100003260 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 01/07/2010 | US20100003254 Antibody Substituting for Function of Blood Coagulation Factor VIII |
| 01/07/2010 | US20100003199 Novel Protein Kinase C Therapy for the Treatment of Acute Lung Injury |
| 01/07/2010 | CA2730040A1 An intrauterine delivery system for contraception |
| 01/06/2010 | EP2141178A1 Method of producing antithrombin composition |
| 01/06/2010 | EP2141150A1 Bicyclic compound and pharmaceutical use thereof |
| 01/06/2010 | EP2140867A1 Pharmaceutical composition |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2079711B1 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor antagonists |
| 01/06/2010 | EP1489078B1 Benzofuran derivative |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | CN101619057A N-substituted piperidine derivatives as serotonin receptor agents |
| 01/06/2010 | CN100577677C Caulis trachelospermi total lignans extractive, extraction method and medicine use of the active constituent thereof |
| 01/06/2010 | CN100577198C Medicine for curing cardio-cerebrovascular disease |
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/06/2010 | CN100577162C Substituted oxazolidinones for combinational therapy |
| 01/06/2010 | CN100577159C Myricetin dispersion tablets for treating cardio-cerebral blood vessel diseases and preparation method thereof |
| 01/06/2010 | CN100577158C Method for preparing Tengchasu dispersibletablet and its use |
| 01/05/2010 | US7641925 Mixture of Trigonelline, amino acid and soluble fibers |
| 01/05/2010 | US7641922 Preparation and application of transhintotalphenolic acid |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2349475C Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 12/31/2009 | US20090326510 Drug Delivery Methods and Systems |
| 12/31/2009 | US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use |
| 12/31/2009 | US20090326052 Promoters exhibiting endothelial cell specificity and methods of using same |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090325988 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof |
| 12/31/2009 | US20090325881 Modified factor viii |
| 12/31/2009 | US20090324710 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 12/31/2009 | US20090324670 Polyester Implantable Medical Device With Controlled In Vivo Biodegradability |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324583 Methods for inducing the differentiation of hematopoietic stem cells into megakaryocytes and platelets, and gene controlling the differentiation |
| 12/31/2009 | US20090324545 Polymorphic forms of (s)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl carbamate |
| 12/30/2009 | WO2009158033A2 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 12/30/2009 | WO2009158015A2 Antagonists of actriib and uses for increasing red blood cell levels |
| 12/30/2009 | WO2009157860A1 New heterocyclic carboxamides for use as thrombin inhibitors |
| 12/30/2009 | WO2009157418A1 Carboxylic acid compound |
| 12/30/2009 | WO2009156724A2 Novel compounds |
| 12/30/2009 | WO2009117144A9 Benzazepine compounds |
| 12/30/2009 | EP2138497A1 Novel adenine compound |
| 12/30/2009 | EP2138484A1 Fused bicyclic heteroaryl derivatives |
| 12/30/2009 | EP2138482A1 Bicyclic heterocyclic compound |
| 12/30/2009 | EP1919483B1 Combined preparation of a thiazide diuretic and a loop diuretic |
| 12/30/2009 | EP1678161B1 Thioether-substituted benzamides as inhibitors of factor xa |
| 12/30/2009 | EP0863754B2 Hydrolysis-optimized lipid emulsions and use thereof |
| 12/30/2009 | CN101613688A Von willebrand factor (vWF)-cleaving protease |
| 12/30/2009 | CN101612402A Interferon antagonist and use of Flt3L interferon |
| 12/30/2009 | CN100575492C CDNA sequence of coding perinereis albuhitensis grube protease and amino acid sequence thereof |
| 12/30/2009 | CN100575482C Novel cytokine zcytor17 ligand |
| 12/30/2009 | CN100575364C Antibodies for inhibiting blood coagulation and methods of use thereof |
| 12/30/2009 | CN100575353C Preparation method of methyl thienotetrahydropyridinacetate |
| 12/30/2009 | CN100575334C Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/30/2009 | CN100574803C Use of immunoregulation antibody for the treatment of neoplastic disorders |
| 12/30/2009 | CN100574802C Compound stypticum |
| 12/30/2009 | CN100574791C Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease |
| 12/30/2009 | CN100574758C Compound for treating ischemic related disease |
| 12/30/2009 | CA2729098A1 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 12/30/2009 | CA2729054A1 Antagonists of actriib and uses for increasing red blood cell levels |
| 12/30/2009 | CA2728708A1 Factor viii muteins with reduced immunogenicity |
| 12/30/2009 | CA2727925A1 New heterocyclic carboxamides for use as thrombin inhibitors |
| 12/30/2009 | CA2727340A1 Carboxylic acid compound |
| 12/30/2009 | CA2726894A1 Therapeutic agents comprising elastin-like peptides |
| 12/29/2009 | US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 12/29/2009 | US7638546 Imidazolyl derivatives |
| 12/29/2009 | US7638536 N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]-3-fluoro-4-hydroxybenzamide; nonpeptide c-mpl ligand; low immunogenicity; proliferate human c-mpl-Ba/F3 cells; increase platelets by promoting the formation of megakaryocytic colonies; orally |
| 12/29/2009 | US7638524 For reducing serum cholesterol in a mammal |
| 12/29/2009 | US7638521 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 12/29/2009 | US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/29/2009 | US7638300 In vivo incorporation of unnatural amino acids |
| 12/29/2009 | US7638141 Generating multipotent cells from sstem cells isolated from residual cord blood; tissue engineering and regenerative medicine |
| 12/29/2009 | CA2465349C Transdermal drug for the treatment of neural paralysis and dysfunction |